| __timestamp | Dynavax Technologies Corporation | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 14182353 |
| Thursday, January 1, 2015 | 86943000 | 15503028 |
| Friday, January 1, 2016 | 84493000 | 16183585 |
| Sunday, January 1, 2017 | 64988000 | 22382849 |
| Monday, January 1, 2018 | 74951000 | 33038206 |
| Tuesday, January 1, 2019 | 62331000 | 31777040 |
| Wednesday, January 1, 2020 | 28607000 | 41464134 |
| Friday, January 1, 2021 | 32228000 | 67178053 |
| Saturday, January 1, 2022 | 46600000 | 52531000 |
| Sunday, January 1, 2023 | 54886000 | 68914000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Dynavax Technologies Corporation and Pharming Group N.V. have shown contrasting trends in their R&D investments.
From 2014 to 2023, Dynavax's R&D expenses have fluctuated significantly. Starting strong in 2014 with a peak investment, their spending saw a notable dip in 2020, dropping by nearly 66% from their 2015 high. However, a resurgence is evident as of 2023, with a 92% increase from the 2020 low.
In contrast, Pharming Group N.V. has steadily increased its R&D spending, with a remarkable 386% growth from 2014 to 2023. This consistent rise underscores their strategic focus on long-term innovation.
These trends highlight the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and market positioning.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
Pfizer Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation
R&D Spending Showdown: argenx SE vs Dynavax Technologies Corporation
BeiGene, Ltd. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Dynavax Technologies Corporation
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
R&D Spending Showdown: Verona Pharma plc vs Dynavax Technologies Corporation
Apellis Pharmaceuticals, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Catalyst Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?